Google Answers: Reimbursement for Alzheimer's Drugs in the US

View Question

Q: Reimbursement for Alzheimer's Drugs in the US ( No Answer, 0 Comments )

Question

Subject: Reimbursement for Alzheimer's Drugs in the US
Category: Health > Medicine
Asked by: mq123-ga
List Price: $50.00

Posted: 19 Dec 2005 14:54 PST
Expires: 09 Jan 2006 05:54 PST
Question ID: 607658

What are the major sources of reimbursement in the United States for
Alzheimer?s disease drugs (Aricept, Razadyne, Exelon, and Namenda)?
Specifically, what portion of sales (looking at the class as a whole)
are paid for by Medicare, Medicaid, third-party (private) insurers,
and self-pay (individual consumers)?

Answer

There is no answer at this time.

Comments

There are no comments at this time.

Important Disclaimer: Answers and comments provided on Google Answers are general information, and are not intended to substitute for informed professional medical, psychiatric, psychological, tax, legal, investment, accounting, or other professional advice. Google does not endorse, and expressly disclaims liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in answers or comments. Please read carefully the Google Answers Terms of Service.

If you feel that you have found inappropriate content, please let us know by emailing us at answers-support@google.com with the question ID listed above. Thank you.

Search Google Answers for

Google Home - Answers FAQ - Terms of Service - Privacy Policy